Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD
Olga Hartwig, Maryam A. Shetab Boushehri, Karim S. Shalaby, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113828-113828
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Interactions between Nanoparticles and Intestine
Manuela Vitulo, Elisa Gnodi, Raffaella Meneveri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4339-4339
Open Access | Times Cited: 62
Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel disease
Yi Chen, Mingju Shui, Qin Yuan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 510-540
Closed Access | Times Cited: 36
ROS-responsive nanoparticles targeting inflamed colon for synergistic therapy of inflammatory bowel disease via barrier repair and anti-inflammation
Ding Wang, Qi Jiang, Ruoyu Shen, et al.
Nano Research (2024) Vol. 17, Iss. 6, pp. 5409-5423
Closed Access | Times Cited: 14
Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis
Walaa A. El‐Dakroury, Moataz B. Zewail, Gihan F. Asaad, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 196, pp. 114205-114205
Closed Access | Times Cited: 14
Oral Delivery of Pterostilbene by L-Arginine-Mediated “Nano-Bomb” Carrier for the Treatment of Ulcerative Colitis
Wei Wei, Yujie Zhang, Runqing Li, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 603-616
Open Access | Times Cited: 33
Synthesis and Characterization of Acrylamide/Acrylic Acid Co-Polymers and Glutaraldehyde Crosslinked pH-Sensitive Hydrogels
Munir Ahmad Khan, Abul Kalam Azad, Muhammad Safdar, et al.
Gels (2022) Vol. 8, Iss. 1, pp. 47-47
Open Access | Times Cited: 30
Dual-targeting celecoxib nanoparticles protect intestinal epithelium and regulate macrophage polarization for ulcerative colitis treatment
Ruijie Chen, Xinlu Lin, Qian Wang, et al.
Chemical Engineering Journal (2022) Vol. 452, pp. 139445-139445
Closed Access | Times Cited: 30
Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment
Lei Qiu, Renbin Shen, Lei Wei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
Sílvio André Lopes, Cesar Augusto Roque‐Borda, Jonatas Lobato Duarte, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2600-2600
Open Access | Times Cited: 20
Oral colon-targeted responsive alginate/hyaluronic acid-based hydrogel propels the application of infliximab in colitis
Manxiu Huai, Mingliang Pei, Jiaxing Pan, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125952-125952
Closed Access | Times Cited: 18
From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems
Jiaojiao Yang, Dingwei Li, Mengjiao Zhang, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 568-591
Closed Access | Times Cited: 17
Current applications of intestinal organoids: a review
Tao Xiang, Jie Wang, Hui Li
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Trends in 3D models of inflammatory bowel disease
Bárbara Ferreira, Andreia S. Barros, Catarina Leite Pereira, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167042-167042
Open Access | Times Cited: 6
Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease
Ping Liu, Yixuan Li, Ran Wang, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 85-85
Open Access | Times Cited: 35
Alginate/silk fibroin/Zn2+ composite microspheres for site-specific delivery for enhanced ulcerative colitis therapy
Yaoyao Du, Yuting Jiang, Yijie Song, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153441-153441
Closed Access | Times Cited: 5
Current Landscape and Emerging Opportunities of Gene Therapy with Non-viral Episomal Vectors
Safir Ullah Khan, Munir Ullah Khan, Muhammad Imran Khan, et al.
Current Gene Therapy (2022) Vol. 23, Iss. 2, pp. 135-147
Closed Access | Times Cited: 20
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Cheng Chen, Ana Beloqui, Yining Xu
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115117-115117
Closed Access | Times Cited: 13
Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport
Vincent Lenders, Xanthippi Koutsoumpou, Philana Phan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 14, pp. 4672-4724
Open Access | Times Cited: 12
A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD
Jing Lv, Yousif Saleh Ibrahim, Alexey Yumashev, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112486-112486
Closed Access | Times Cited: 4
Orally administrated liquid metal agents for inflammation-targeted alleviation of inflammatory bowel diseases
Miaodeng Liu, Jinhui Zou, H. Li, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 4
Iron Regulatory Protein 1 is Required for the Propagation of Inflammation in Inflammatory Bowel Disease
Lulu Fahoum, Shirly Moshe-Belisowski, Kristina Zaydel, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107639-107639
Open Access | Times Cited: 4
Preclinical and clinical status of nanocarriers for colon targeting
Brian Villa, Melissa Chow, Sami Soliman, et al.
Elsevier eBooks (2025), pp. 717-757
Closed Access
Precisely edited gut microbiota by tungsten-doped Prussian blue nanoparticles for the treatment of inflammatory bowel disease
Lizhu Luo, Qingyun Liu, Y. Zhang, et al.
Journal of Controlled Release (2025) Vol. 382, pp. 113755-113755
Closed Access
Reactive Oxygen Species-Responsive Polymer Drug Delivery System Targeted Oxidative Stressed Colon Cells to Ameliorate Colitis
Wo-Qi Cai, Wanqi Liang, Dong Li, et al.
ACS Nano (2025)
Closed Access
Page 1 - Next Page

Scroll to top